Drug Shortage Report for AZARGA
Report ID | 54440 |
Drug Identification Number | 02331624 |
Brand name | AZARGA |
Common or Proper name | AZARGA OPH SUSP 5ML |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TIMOLOL BRINZOLAMIDE |
Strength(s) | 0.5% 1.0% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | 5ML |
ATC code | S01ED |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2018-06-25 |
Estimated end date | 2018-07-25 |
Actual end date | 2018-07-25 |
Shortage status | Resolved |
Updated date | 2018-07-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-07-27 | French | Compare |
v7 | 2018-07-27 | English | Compare |
v6 | 2018-07-20 | French | Compare |
v5 | 2018-07-20 | English | Compare |
v4 | 2018-07-11 | French | Compare |
v3 | 2018-07-11 | English | Compare |
v2 | 2018-07-05 | French | Compare |
v1 | 2018-07-05 | English | Compare |
Showing 1 to 8 of 8